Skip to main content

Table 2 Baseline, 12 and 24 week scores: values are mean (SD) unless stated otherwise

From: Clinical effectiveness of a web-based peer-supported self-management intervention for relatives of people with psychosis or bipolar (REACT): online, observer-blind, randomised controlled superiority trial

 REACTRDTotal
GHQ-28
 Baseline40.3 (14.6)40.0 (14.0)40.2 (14.3)
 12 weeks30.6 (15.2)32.9 (15.4)31.8 (15.3)
 24 weeks29.6 (15.9)31.3 (15.2)30.5 (15.6)
GHQ-28 subscales
 Somatic symptoms
  Baseline10.3 (4.4)10.4 (4.0)10.3 (4.2)
  12 weeks8.1 (4.3)8.7 (4.4)8.4 (4.4)
  24 weeks7.9 (4.7)8.3 (4.5)8.1 (4.6)
 Anxiety/insomnia
  Baseline13.0 (4.1)12.9 (4.0)13.0 (4.1)
  12 weeks9.5 (4.7)10.1 (4.8)9.8 (4.7)
  24 weeks9.2 (4.9)9.9 (4.9)9.6 (4.9)
 Social dysfunction: note that values are median (IQR)
  Baseline11 (8–13)11 (8–14)11 (8–13.5)
  12 weeks8 (7–11)9 (7–13)9 (7–12)
  24 weeks8 (7–11)8 (7–11)8 (7–11)
 Severe depression: note that values are median (IQR)
  Baseline4 (1–9)4 (1–9)4 (1–9)
  12 weeks2 (0–7)3 (0–7)2 (0–7)
  24 weeks2 (0–6)2 (0–7)2 (0–7)
CWS - wellbeing
 Baseline55.9 (25.9)55.8 (26.4)55.9 (26.1)
 12 weeks72.0 (27.0)68.9 (27.7)70.3 (27.4)
 24 weeks77.0 (26.6)72.6 (30.5)74.7 (28.8)
CWS - support
 Baseline19.5 (11.6)18.8 (11.7)19.1 (11.7)
 12 weeks26.0 (12.0)22.6 (12.0)24.2 (12.1)
 24 weeks25.7 (11.7)23.2 (12.2)24.4 (12.0)